The global market for Sorafenib API is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Sorafenib API market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Sorafenib API market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Sorafenib API market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Sorafenib API market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Sorafenib API players cover Hunan Huateng Pharmaceutical, Anhui HaiKang Pharmaceutical, Chongqing Carelife Pharmaceutical, Sichuan Xieli Pharmaceutical and NEWEDGE Overseas, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Sorafenib API market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Sorafenib API market, with both quantitative and qualitative data, to help readers understand how the Sorafenib API market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in Tons.
Market Segmentation:
The study segments the Sorafenib API market and forecasts the market size by Purity (0.99, 0.995 and 0.999), by Application (Tablets and Others.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by purity
0.99
0.995
0.999
Others
Segmentation by application
Tablets
Others
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Hunan Huateng Pharmaceutical
Anhui HaiKang Pharmaceutical
Chongqing Carelife Pharmaceutical
Sichuan Xieli Pharmaceutical
NEWEDGE Overseas
KriSan Biotech
Teva API
Alembic Pharmaceuticals
Aurobindo Pharma
BDR Pharmaceuticals
Biotechnica Pharma Global
Bulat Pharmaceutical
Cdymax
Estechpharma
Jeil Pharmaceutical
MSN Laboratories
Stason Pharmaceuticals
Vannsh Life Sciences
Chapter Introduction
Chapter 1: Scope of Sorafenib API, Research Methodology, etc.
Chapter 2: Executive Summary, global Sorafenib API market size (sales and revenue) and CAGR, Sorafenib API market size by region, by purity, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Sorafenib API sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Sorafenib API sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by purity, and purity.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Sorafenib API market size forecast by region, by country, by purity, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Hunan Huateng Pharmaceutical, Anhui HaiKang Pharmaceutical, Chongqing Carelife Pharmaceutical, Sichuan Xieli Pharmaceutical, NEWEDGE Overseas, KriSan Biotech, Teva API, Alembic Pharmaceuticals and Aurobindo Pharma, etc.
Chapter 14: Research Findings and Conclusion
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Sorafenib API Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Sorafenib API by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Sorafenib API by Country/Region, 2017, 2022 & 2028
2.2 Sorafenib API Segment by Purity
2.2.1 0.99
2.2.2 0.995
2.2.3 0.999
2.2.4 Others
2.3 Sorafenib API Sales by Purity
2.3.1 Global Sorafenib API Sales Market Share by Purity (2017-2022)
2.3.2 Global Sorafenib API Revenue and Market Share by Purity (2017-2022)
2.3.3 Global Sorafenib API Sale Price by Purity (2017-2022)
2.4 Sorafenib API Segment by Application
2.4.1 Tablets
2.4.2 Others
2.5 Sorafenib API Sales by Application
2.5.1 Global Sorafenib API Sale Market Share by Application (2017-2022)
2.5.2 Global Sorafenib API Revenue and Market Share by Application (2017-2022)
2.5.3 Global Sorafenib API Sale Price by Application (2017-2022)
3 Global Sorafenib API by Company
3.1 Global Sorafenib API Breakdown Data by Company
3.1.1 Global Sorafenib API Annual Sales by Company (2020-2022)
3.1.2 Global Sorafenib API Sales Market Share by Company (2020-2022)
3.2 Global Sorafenib API Annual Revenue by Company (2020-2022)
3.2.1 Global Sorafenib API Revenue by Company (2020-2022)
3.2.2 Global Sorafenib API Revenue Market Share by Company (2020-2022)
3.3 Global Sorafenib API Sale Price by Company
3.4 Key Manufacturers Sorafenib API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Sorafenib API Product Location Distribution
3.4.2 Players Sorafenib API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Sorafenib API by Geographic Region
4.1 World Historic Sorafenib API Market Size by Geographic Region (2017-2022)
4.1.1 Global Sorafenib API Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Sorafenib API Annual Revenue by Geographic Region
4.2 World Historic Sorafenib API Market Size by Country/Region (2017-2022)
4.2.1 Global Sorafenib API Annual Sales by Country/Region (2017-2022)
4.2.2 Global Sorafenib API Annual Revenue by Country/Region
4.3 Americas Sorafenib API Sales Growth
4.4 APAC Sorafenib API Sales Growth
4.5 Europe Sorafenib API Sales Growth
4.6 Middle East & Africa Sorafenib API Sales Growth
5 Americas
5.1 Americas Sorafenib API Sales by Country
5.1.1 Americas Sorafenib API Sales by Country (2017-2022)
5.1.2 Americas Sorafenib API Revenue by Country (2017-2022)
5.2 Americas Sorafenib API Sales by Purity
5.3 Americas Sorafenib API Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Sorafenib API Sales by Region
6.1.1 APAC Sorafenib API Sales by Region (2017-2022)
6.1.2 APAC Sorafenib API Revenue by Region (2017-2022)
6.2 APAC Sorafenib API Sales by Purity
6.3 APAC Sorafenib API Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Sorafenib API by Country
7.1.1 Europe Sorafenib API Sales by Country (2017-2022)
7.1.2 Europe Sorafenib API Revenue by Country (2017-2022)
7.2 Europe Sorafenib API Sales by Purity
7.3 Europe Sorafenib API Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Sorafenib API by Country
8.1.1 Middle East & Africa Sorafenib API Sales by Country (2017-2022)
8.1.2 Middle East & Africa Sorafenib API Revenue by Country (2017-2022)
8.2 Middle East & Africa Sorafenib API Sales by Purity
8.3 Middle East & Africa Sorafenib API Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Sorafenib API
10.3 Manufacturing Process Analysis of Sorafenib API
10.4 Industry Chain Structure of Sorafenib API
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Sorafenib API Distributors
11.3 Sorafenib API Customer
12 World Forecast Review for Sorafenib API by Geographic Region
12.1 Global Sorafenib API Market Size Forecast by Region
12.1.1 Global Sorafenib API Forecast by Region (2023-2028)
12.1.2 Global Sorafenib API Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Sorafenib API Forecast by Purity
12.7 Global Sorafenib API Forecast by Application
13 Key Players Analysis
13.1 Hunan Huateng Pharmaceutical
13.1.1 Hunan Huateng Pharmaceutical Company Information
13.1.2 Hunan Huateng Pharmaceutical Sorafenib API Product Offered
13.1.3 Hunan Huateng Pharmaceutical Sorafenib API Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Hunan Huateng Pharmaceutical Main Business Overview
13.1.5 Hunan Huateng Pharmaceutical Latest Developments
13.2 Anhui HaiKang Pharmaceutical
13.2.1 Anhui HaiKang Pharmaceutical Company Information
13.2.2 Anhui HaiKang Pharmaceutical Sorafenib API Product Offered
13.2.3 Anhui HaiKang Pharmaceutical Sorafenib API Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Anhui HaiKang Pharmaceutical Main Business Overview
13.2.5 Anhui HaiKang Pharmaceutical Latest Developments
13.3 Chongqing Carelife Pharmaceutical
13.3.1 Chongqing Carelife Pharmaceutical Company Information
13.3.2 Chongqing Carelife Pharmaceutical Sorafenib API Product Offered
13.3.3 Chongqing Carelife Pharmaceutical Sorafenib API Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Chongqing Carelife Pharmaceutical Main Business Overview
13.3.5 Chongqing Carelife Pharmaceutical Latest Developments
13.4 Sichuan Xieli Pharmaceutical
13.4.1 Sichuan Xieli Pharmaceutical Company Information
13.4.2 Sichuan Xieli Pharmaceutical Sorafenib API Product Offered
13.4.3 Sichuan Xieli Pharmaceutical Sorafenib API Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Sichuan Xieli Pharmaceutical Main Business Overview
13.4.5 Sichuan Xieli Pharmaceutical Latest Developments
13.5 NEWEDGE Overseas
13.5.1 NEWEDGE Overseas Company Information
13.5.2 NEWEDGE Overseas Sorafenib API Product Offered
13.5.3 NEWEDGE Overseas Sorafenib API Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 NEWEDGE Overseas Main Business Overview
13.5.5 NEWEDGE Overseas Latest Developments
13.6 KriSan Biotech
13.6.1 KriSan Biotech Company Information
13.6.2 KriSan Biotech Sorafenib API Product Offered
13.6.3 KriSan Biotech Sorafenib API Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 KriSan Biotech Main Business Overview
13.6.5 KriSan Biotech Latest Developments
13.7 Teva API
13.7.1 Teva API Company Information
13.7.2 Teva API Sorafenib API Product Offered
13.7.3 Teva API Sorafenib API Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Teva API Main Business Overview
13.7.5 Teva API Latest Developments
13.8 Alembic Pharmaceuticals
13.8.1 Alembic Pharmaceuticals Company Information
13.8.2 Alembic Pharmaceuticals Sorafenib API Product Offered
13.8.3 Alembic Pharmaceuticals Sorafenib API Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Alembic Pharmaceuticals Main Business Overview
13.8.5 Alembic Pharmaceuticals Latest Developments
13.9 Aurobindo Pharma
13.9.1 Aurobindo Pharma Company Information
13.9.2 Aurobindo Pharma Sorafenib API Product Offered
13.9.3 Aurobindo Pharma Sorafenib API Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Aurobindo Pharma Main Business Overview
13.9.5 Aurobindo Pharma Latest Developments
13.10 BDR Pharmaceuticals
13.10.1 BDR Pharmaceuticals Company Information
13.10.2 BDR Pharmaceuticals Sorafenib API Product Offered
13.10.3 BDR Pharmaceuticals Sorafenib API Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 BDR Pharmaceuticals Main Business Overview
13.10.5 BDR Pharmaceuticals Latest Developments
13.11 Biotechnica Pharma Global
13.11.1 Biotechnica Pharma Global Company Information
13.11.2 Biotechnica Pharma Global Sorafenib API Product Offered
13.11.3 Biotechnica Pharma Global Sorafenib API Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Biotechnica Pharma Global Main Business Overview
13.11.5 Biotechnica Pharma Global Latest Developments
13.12 Bulat Pharmaceutical
13.12.1 Bulat Pharmaceutical Company Information
13.12.2 Bulat Pharmaceutical Sorafenib API Product Offered
13.12.3 Bulat Pharmaceutical Sorafenib API Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Bulat Pharmaceutical Main Business Overview
13.12.5 Bulat Pharmaceutical Latest Developments
13.13 Cdymax
13.13.1 Cdymax Company Information
13.13.2 Cdymax Sorafenib API Product Offered
13.13.3 Cdymax Sorafenib API Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Cdymax Main Business Overview
13.13.5 Cdymax Latest Developments
13.14 Estechpharma
13.14.1 Estechpharma Company Information
13.14.2 Estechpharma Sorafenib API Product Offered
13.14.3 Estechpharma Sorafenib API Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Estechpharma Main Business Overview
13.14.5 Estechpharma Latest Developments
13.15 Jeil Pharmaceutical
13.15.1 Jeil Pharmaceutical Company Information
13.15.2 Jeil Pharmaceutical Sorafenib API Product Offered
13.15.3 Jeil Pharmaceutical Sorafenib API Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Jeil Pharmaceutical Main Business Overview
13.15.5 Jeil Pharmaceutical Latest Developments
13.16 MSN Laboratories
13.16.1 MSN Laboratories Company Information
13.16.2 MSN Laboratories Sorafenib API Product Offered
13.16.3 MSN Laboratories Sorafenib API Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 MSN Laboratories Main Business Overview
13.16.5 MSN Laboratories Latest Developments
13.17 Stason Pharmaceuticals
13.17.1 Stason Pharmaceuticals Company Information
13.17.2 Stason Pharmaceuticals Sorafenib API Product Offered
13.17.3 Stason Pharmaceuticals Sorafenib API Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Stason Pharmaceuticals Main Business Overview
13.17.5 Stason Pharmaceuticals Latest Developments
13.18 Vannsh Life Sciences
13.18.1 Vannsh Life Sciences Company Information
13.18.2 Vannsh Life Sciences Sorafenib API Product Offered
13.18.3 Vannsh Life Sciences Sorafenib API Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 Vannsh Life Sciences Main Business Overview
13.18.5 Vannsh Life Sciences Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Sorafenib API Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Sorafenib API Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 0.99
Table 4. Major Players of 0.995
Table 5. Major Players of 0.999
Table 6. Major Players of Others
Table 7. Global Sorafenib API Sales by Purity (2017-2022) & (Tons)
Table 8. Global Sorafenib API Sales Market Share by Purity (2017-2022)
Table 9. Global Sorafenib API Revenue by Purity (2017-2022) & ($ million)
Table 10. Global Sorafenib API Revenue Market Share by Purity (2017-2022)
Table 11. Global Sorafenib API Sale Price by Purity (2017-2022) & (US$/Kg)
Table 12. Global Sorafenib API Sales by Application (2017-2022) & (Tons)
Table 13. Global Sorafenib API Sales Market Share by Application (2017-2022)
Table 14. Global Sorafenib API Revenue by Application (2017-2022)
Table 15. Global Sorafenib API Revenue Market Share by Application (2017-2022)
Table 16. Global Sorafenib API Sale Price by Application (2017-2022) & (US$/Kg)
Table 17. Global Sorafenib API Sales by Company (2020-2022) & (Tons)
Table 18. Global Sorafenib API Sales Market Share by Company (2020-2022)
Table 19. Global Sorafenib API Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Sorafenib API Revenue Market Share by Company (2020-2022)
Table 21. Global Sorafenib API Sale Price by Company (2020-2022) & (US$/Kg)
Table 22. Key Manufacturers Sorafenib API Producing Area Distribution and Sales Area
Table 23. Players Sorafenib API Products Offered
Table 24. Sorafenib API Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Sorafenib API Sales by Geographic Region (2017-2022) & (Tons)
Table 28. Global Sorafenib API Sales Market Share Geographic Region (2017-2022)
Table 29. Global Sorafenib API Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Sorafenib API Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Sorafenib API Sales by Country/Region (2017-2022) & (Tons)
Table 32. Global Sorafenib API Sales Market Share by Country/Region (2017-2022)
Table 33. Global Sorafenib API Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Sorafenib API Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Sorafenib API Sales by Country (2017-2022) & (Tons)
Table 36. Americas Sorafenib API Sales Market Share by Country (2017-2022)
Table 37. Americas Sorafenib API Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Sorafenib API Revenue Market Share by Country (2017-2022)
Table 39. Americas Sorafenib API Sales by Type (2017-2022) & (Tons)
Table 40. Americas Sorafenib API Sales Market Share by Purity (2017-2022)
Table 41. Americas Sorafenib API Sales by Application (2017-2022) & (Tons)
Table 42. Americas Sorafenib API Sales Market Share by Application (2017-2022)
Table 43. APAC Sorafenib API Sales by Region (2017-2022) & (Tons)
Table 44. APAC Sorafenib API Sales Market Share by Region (2017-2022)
Table 45. APAC Sorafenib API Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Sorafenib API Revenue Market Share by Region (2017-2022)
Table 47. APAC Sorafenib API Sales by Purity (2017-2022) & (Tons)
Table 48. APAC Sorafenib API Sales Market Share by Purity (2017-2022)
Table 49. APAC Sorafenib API Sales by Application (2017-2022) & (Tons)
Table 50. APAC Sorafenib API Sales Market Share by Application (2017-2022)
Table 51. Europe Sorafenib API Sales by Country (2017-2022) & (Tons)
Table 52. Europe Sorafenib API Sales Market Share by Country (2017-2022)
Table 53. Europe Sorafenib API Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Sorafenib API Revenue Market Share by Country (2017-2022)
Table 55. Europe Sorafenib API Sales by Type (2017-2022) & (Tons)
Table 56. Europe Sorafenib API Sales Market Share by Purity (2017-2022)
Table 57. Europe Sorafenib API Sales by Application (2017-2022) & (Tons)
Table 58. Europe Sorafenib API Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Sorafenib API Sales by Country (2017-2022) & (Tons)
Table 60. Middle East & Africa Sorafenib API Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Sorafenib API Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Sorafenib API Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Sorafenib API Sales by Purity (2017-2022) & (Tons)
Table 64. Middle East & Africa Sorafenib API Sales Market Share by Purity (2017-2022)
Table 65. Middle East & Africa Sorafenib API Sales by Application (2017-2022) & (Tons)
Table 66. Middle East & Africa Sorafenib API Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Sorafenib API
Table 68. Key Market Challenges & Risks of Sorafenib API
Table 69. Key Industry Trends of Sorafenib API
Table 70. Sorafenib API Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Sorafenib API Distributors List
Table 73. Sorafenib API Customer List
Table 74. Global Sorafenib API Sales Forecast by Region (2023-2028) & (Tons)
Table 75. Global Sorafenib API Sales Market Forecast by Region
Table 76. Global Sorafenib API Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Sorafenib API Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Sorafenib API Sales Forecast by Country (2023-2028) & (Tons)
Table 79. Americas Sorafenib API Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Sorafenib API Sales Forecast by Region (2023-2028) & (Tons)
Table 81. APAC Sorafenib API Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Sorafenib API Sales Forecast by Country (2023-2028) & (Tons)
Table 83. Europe Sorafenib API Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Sorafenib API Sales Forecast by Country (2023-2028) & (Tons)
Table 85. Middle East & Africa Sorafenib API Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Sorafenib API Sales Forecast by Purity (2023-2028) & (Tons)
Table 87. Global Sorafenib API Sales Market Share Forecast by Purity (2023-2028)
Table 88. Global Sorafenib API Revenue Forecast by Purity (2023-2028) & ($ Millions)
Table 89. Global Sorafenib API Revenue Market Share Forecast by Purity (2023-2028)
Table 90. Global Sorafenib API Sales Forecast by Application (2023-2028) & (Tons)
Table 91. Global Sorafenib API Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Sorafenib API Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Sorafenib API Revenue Market Share Forecast by Application (2023-2028)
Table 94. Hunan Huateng Pharmaceutical Basic Information, Sorafenib API Manufacturing Base, Sales Area and Its Competitors
Table 95. Hunan Huateng Pharmaceutical Sorafenib API Product Offered
Table 96. Hunan Huateng Pharmaceutical Sorafenib API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 97. Hunan Huateng Pharmaceutical Main Business
Table 98. Hunan Huateng Pharmaceutical Latest Developments
Table 99. Anhui HaiKang Pharmaceutical Basic Information, Sorafenib API Manufacturing Base, Sales Area and Its Competitors
Table 100. Anhui HaiKang Pharmaceutical Sorafenib API Product Offered
Table 101. Anhui HaiKang Pharmaceutical Sorafenib API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 102. Anhui HaiKang Pharmaceutical Main Business
Table 103. Anhui HaiKang Pharmaceutical Latest Developments
Table 104. Chongqing Carelife Pharmaceutical Basic Information, Sorafenib API Manufacturing Base, Sales Area and Its Competitors
Table 105. Chongqing Carelife Pharmaceutical Sorafenib API Product Offered
Table 106. Chongqing Carelife Pharmaceutical Sorafenib API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 107. Chongqing Carelife Pharmaceutical Main Business
Table 108. Chongqing Carelife Pharmaceutical Latest Developments
Table 109. Sichuan Xieli Pharmaceutical Basic Information, Sorafenib API Manufacturing Base, Sales Area and Its Competitors
Table 110. Sichuan Xieli Pharmaceutical Sorafenib API Product Offered
Table 111. Sichuan Xieli Pharmaceutical Sorafenib API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 112. Sichuan Xieli Pharmaceutical Main Business
Table 113. Sichuan Xieli Pharmaceutical Latest Developments
Table 114. NEWEDGE Overseas Basic Information, Sorafenib API Manufacturing Base, Sales Area and Its Competitors
Table 115. NEWEDGE Overseas Sorafenib API Product Offered
Table 116. NEWEDGE Overseas Sorafenib API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 117. NEWEDGE Overseas Main Business
Table 118. NEWEDGE Overseas Latest Developments
Table 119. KriSan Biotech Basic Information, Sorafenib API Manufacturing Base, Sales Area and Its Competitors
Table 120. KriSan Biotech Sorafenib API Product Offered
Table 121. KriSan Biotech Sorafenib API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 122. KriSan Biotech Main Business
Table 123. KriSan Biotech Latest Developments
Table 124. Teva API Basic Information, Sorafenib API Manufacturing Base, Sales Area and Its Competitors
Table 125. Teva API Sorafenib API Product Offered
Table 126. Teva API Sorafenib API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 127. Teva API Main Business
Table 128. Teva API Latest Developments
Table 129. Alembic Pharmaceuticals Basic Information, Sorafenib API Manufacturing Base, Sales Area and Its Competitors
Table 130. Alembic Pharmaceuticals Sorafenib API Product Offered
Table 131. Alembic Pharmaceuticals Sorafenib API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 132. Alembic Pharmaceuticals Main Business
Table 133. Alembic Pharmaceuticals Latest Developments
Table 134. Aurobindo Pharma Basic Information, Sorafenib API Manufacturing Base, Sales Area and Its Competitors
Table 135. Aurobindo Pharma Sorafenib API Product Offered
Table 136. Aurobindo Pharma Sorafenib API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 137. Aurobindo Pharma Main Business
Table 138. Aurobindo Pharma Latest Developments
Table 139. BDR Pharmaceuticals Basic Information, Sorafenib API Manufacturing Base, Sales Area and Its Competitors
Table 140. BDR Pharmaceuticals Sorafenib API Product Offered
Table 141. BDR Pharmaceuticals Sorafenib API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 142. BDR Pharmaceuticals Main Business
Table 143. BDR Pharmaceuticals Latest Developments
Table 144. Biotechnica Pharma Global Basic Information, Sorafenib API Manufacturing Base, Sales Area and Its Competitors
Table 145. Biotechnica Pharma Global Sorafenib API Product Offered
Table 146. Biotechnica Pharma Global Sorafenib API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 147. Biotechnica Pharma Global Main Business
Table 148. Biotechnica Pharma Global Latest Developments
Table 149. Bulat Pharmaceutical Basic Information, Sorafenib API Manufacturing Base, Sales Area and Its Competitors
Table 150. Bulat Pharmaceutical Sorafenib API Product Offered
Table 151. Bulat Pharmaceutical Sorafenib API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 152. Bulat Pharmaceutical Main Business
Table 153. Bulat Pharmaceutical Latest Developments
Table 154. Cdymax Basic Information, Sorafenib API Manufacturing Base, Sales Area and Its Competitors
Table 155. Cdymax Sorafenib API Product Offered
Table 156. Cdymax Sorafenib API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 157. Cdymax Main Business
Table 158. Cdymax Latest Developments
Table 159. Estechpharma Basic Information, Sorafenib API Manufacturing Base, Sales Area and Its Competitors
Table 160. Estechpharma Sorafenib API Product Offered
Table 161. Estechpharma Sorafenib API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 162. Estechpharma Main Business
Table 163. Estechpharma Latest Developments
Table 164. Jeil Pharmaceutical Basic Information, Sorafenib API Manufacturing Base, Sales Area and Its Competitors
Table 165. Jeil Pharmaceutical Sorafenib API Product Offered
Table 166. Jeil Pharmaceutical Sorafenib API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 167. Jeil Pharmaceutical Main Business
Table 168. Jeil Pharmaceutical Latest Developments
Table 169. MSN Laboratories Basic Information, Sorafenib API Manufacturing Base, Sales Area and Its Competitors
Table 170. MSN Laboratories Sorafenib API Product Offered
Table 171. MSN Laboratories Sorafenib API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 172. MSN Laboratories Main Business
Table 173. MSN Laboratories Latest Developments
Table 174. Stason Pharmaceuticals Basic Information, Sorafenib API Manufacturing Base, Sales Area and Its Competitors
Table 175. Stason Pharmaceuticals Sorafenib API Product Offered
Table 176. Stason Pharmaceuticals Sorafenib API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 177. Stason Pharmaceuticals Main Business
Table 178. Stason Pharmaceuticals Latest Developments
Table 179. Vannsh Life Sciences Basic Information, Sorafenib API Manufacturing Base, Sales Area and Its Competitors
Table 180. Vannsh Life Sciences Sorafenib API Product Offered
Table 181. Vannsh Life Sciences Sorafenib API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 182. Vannsh Life Sciences Main Business
Table 183. Vannsh Life Sciences Latest Developments
List of Figures
Figure 1. Picture of Sorafenib API
Figure 2. Sorafenib API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Sorafenib API Sales Growth Rate 2017-2028 (Tons)
Figure 7. Global Sorafenib API Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Sorafenib API Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 0.99
Figure 10. Product Picture of 0.995
Figure 11. Product Picture of 0.999
Figure 12. Product Picture of Others
Figure 13. Global Sorafenib API Sales Market Share by Purity in 2021
Figure 14. Global Sorafenib API Revenue Market Share by Purity (2017-2022)
Figure 15. Sorafenib API Consumed in Tablets
Figure 16. Global Sorafenib API Market: Tablets (2017-2022) & (Tons)
Figure 17. Sorafenib API Consumed in Others
Figure 18. Global Sorafenib API Market: Others (2017-2022) & (Tons)
Figure 19. Global Sorafenib API Sales Market Share by Application (2017-2022)
Figure 20. Global Sorafenib API Revenue Market Share by Application in 2021
Figure 21. Sorafenib API Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Sorafenib API Revenue Market Share by Company in 2021
Figure 23. Global Sorafenib API Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Sorafenib API Revenue Market Share by Geographic Region in 2021
Figure 25. Global Sorafenib API Sales Market Share by Region (2017-2022)
Figure 26. Global Sorafenib API Revenue Market Share by Country/Region in 2021
Figure 27. Americas Sorafenib API Sales 2017-2022 (Tons)
Figure 28. Americas Sorafenib API Revenue 2017-2022 ($ Millions)
Figure 29. APAC Sorafenib API Sales 2017-2022 (Tons)
Figure 30. APAC Sorafenib API Revenue 2017-2022 ($ Millions)
Figure 31. Europe Sorafenib API Sales 2017-2022 (Tons)
Figure 32. Europe Sorafenib API Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Sorafenib API Sales 2017-2022 (Tons)
Figure 34. Middle East & Africa Sorafenib API Revenue 2017-2022 ($ Millions)
Figure 35. Americas Sorafenib API Sales Market Share by Country in 2021
Figure 36. Americas Sorafenib API Revenue Market Share by Country in 2021
Figure 37. United States Sorafenib API Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Sorafenib API Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Sorafenib API Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Sorafenib API Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Sorafenib API Sales Market Share by Region in 2021
Figure 42. APAC Sorafenib API Revenue Market Share by Regions in 2021
Figure 43. China Sorafenib API Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Sorafenib API Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Sorafenib API Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Sorafenib API Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Sorafenib API Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Sorafenib API Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Sorafenib API Sales Market Share by Country in 2021
Figure 50. Europe Sorafenib API Revenue Market Share by Country in 2021
Figure 51. Germany Sorafenib API Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Sorafenib API Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Sorafenib API Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Sorafenib API Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Sorafenib API Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Sorafenib API Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Sorafenib API Revenue Market Share by Country in 2021
Figure 58. Egypt Sorafenib API Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Sorafenib API Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Sorafenib API Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Sorafenib API Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Sorafenib API Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Sorafenib API in 2021
Figure 64. Manufacturing Process Analysis of Sorafenib API
Figure 65. Industry Chain Structure of Sorafenib API
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
Global Graphitized Carbon Black (GCB) Ma..
Graphitized carbon black is a black particle that can be use..
+16467917070US (Toll Free)